Skip to main navigation Skip to search Skip to main content

Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines

  • Shaji K. Kumar
  • , Natalie S. Callander
  • , Melissa Alsina
  • , Djordje Atanackovic
  • , J. Sybil Biermann
  • , Jorge Castillo
  • , Jason C. Chandler
  • , Caitlin Costello
  • , Matthew Faiman
  • , Henry C. Fung
  • , Kelly Godby
  • , Craig Hofmeister
  • , Leona Holmberg
  • , Sarah Holstein
  • , Carol Ann Huff
  • , Yubin Kang
  • , Adetola Kassim
  • , Michaela Liedtke
  • , Ehsan Malek
  • , Thomas Martin
  • Vishala T. Neppalli, James Omel, Noopur Raje, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Donna Weber, Joachim Yahalom, Rashmi Kumar, Dorothy A. Shead

Research output: Contribution to journalReview articlepeer-review

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.

Original languageEnglish
Pages (from-to)11-20
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Dive into the research topics of 'Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this